Hints and tips:
Related Special Reports
...of the Commanders opened many owners’ eyes to the amount of money involved in buying a team — the financier had syndicated about half of the equity from a broad group of investors, including billionaire healthcare...
...It would be “likely to have the effect of distorting the market in that it restricts supply of private practitioners to PMIs [private medical insurers] which will have effects on consumer choice and access...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...“Unless the case can be made that crypto has meaningfully changed in the last three years, it’s hard to see why the FCA would authorise them,” Prosser said, while the FCA’s Consumer Duty rules requiring...
...However, McNeil said that as the door was only being opened to professionals, “the bar is still too high”....
...However, analysts have pointed out that the majority of US healthcare spending occurs via insurance and that Amazon would need to push further beyond the consumer-facing space into the insured market to...
...Danish drugmaker Novo Nordisk has been “surprised” by the readiness of European consumers to pay for weight-loss drugs from their own pockets, as the region’s largest company invests in new supply to meet...
...Gains for index heavyweights Rio Tinto and Anglo American boosted London’s FTSE 100, although declines in other sectors, particularly for healthcare and consumer stocks, limited gains for the UK’s blue-chip...
...Long-term risks, notes PitchBook healthcare analyst Aaron DeGagne, include heavyweights muscling in....
...Strong growth is expected over the next couple of years in animal food, accessories and healthcare, he said, with an increased number of younger first-time owners making this one of the fastest-growing consumer...
...Healthcare, consumer cyclicals and real estate performed the worst. The tech-heavy Nasdaq Composite fell 1 per cent as six of the Big Tech stocks in the Magnificent Seven declined....
...The addition of Amazon Pharmacy to Eli Lilly’s direct-to-consumer dispensing network is the first time Amazon has partnered with a big drug company since it launched its online pharmacy business in 2020....
...Shares in the consumer goods group fell 15 per cent on Friday last week as investors digested the news that a court in Illinois had instructed Reckitt to pay $60mn in damages to a mother who said her baby...
...About 80 per cent of the index’s constituent stocks finished lower on the day, while healthcare, consumer cyclicals and real estate were the worst-performing sectors....
...Retailers lagged behind the broader Stoxx Europe 600 at the beginning of 2024, as market gains were driven by large healthcare and technology companies, but the sector began to rise in mid-February....
...The company faced controversy a few years later over some of its projects, including its work for the UK healthcare sector, which was found by a government watchdog to have been granted inappropriate access...
...Chewy wants to expand its offerings in pet healthcare. That makes sense. As pets grow older, they need more supplements, vet visits and medications....
...Consumer-sensitive stocks are most exposed to the potential for further defaults in 2024, according to S&P analyst Ekaterina Tolstova....
...All sectors but healthcare and utilities — typically regarded as defensive plays — gained, while financials and consumer cyclicals were the best performers....
...David Furness, director of policy and delivery at the Independent Healthcare Providers Network, an industry body, said: “Nearly nine in 10 companies across the sector feel the market environment for private...
...Barclays analyst Emily Field believes Anderson must “at a minimum” follow the example of Sanofi, which in October named an earliest date by which it intended to carve out its own consumer healthcare business...
...This has raised concerns for the recovery of the world’s second-largest economy, which has failed to revive consumer sentiment as it contends with a long-running property sector slowdown and weaker exports...
...Japan’s rapidly ageing population and increasing demand for prescriptions has resulted in a rise in healthcare expenditure, with Japan’s spending one of the highest among OECD countries as a portion of gross...
...Haleon, the consumer healthcare business spun out of GSK, in February hailed “optimised price pack architecture across the portfolio” in its latest annual report, while in 2022, drinks maker Britvic boasted...
International Edition